<SEC-DOCUMENT>0001178913-14-001976.txt : 20140624
<SEC-HEADER>0001178913-14-001976.hdr.sgml : 20140624
<ACCEPTANCE-DATETIME>20140605061156
ACCESSION NUMBER:		0001178913-14-001976
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20140605
FILED AS OF DATE:		20140605
DATE AS OF CHANGE:		20140605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TOWER SEMICONDUCTOR LTD
		CENTRAL INDEX KEY:			0000928876
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24790
		FILM NUMBER:		14892428

	BUSINESS ADDRESS:	
		STREET 1:		RAMAT GAVRIEL INDUSTRIAL PARK
		STREET 2:		PO BOX 619
		CITY:			MIGDAL HAEMEK
		STATE:			L3
		ZIP:			23105
		BUSINESS PHONE:		97246506611

	MAIL ADDRESS:	
		STREET 1:		RAMAT GAVRIEL INDUSTRIAL PARK
		STREET 2:		PO BOX 619
		CITY:			MIGDAL HAEMEK
		STATE:			L3
		ZIP:			23105
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk1415075.htm
<DESCRIPTION>6-K
<TEXT>
<html>
<head>
    <title>zk1415075.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.4.5.1-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">FORM 6-K</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-VARIANT: small-caps; DISPLAY: inline">W</font>ashington, D.C. <font style="FONT-VARIANT: small-caps; DISPLAY: inline">20549</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-VARIANT: small-caps; DISPLAY: inline">F</font>or the month June 2014 No. 4</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 16pt; FONT-WEIGHT: bold">TOWER SEMICONDUCTOR LTD.</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Translation of registrant's name into English)</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ramat Gavriel Industrial Park</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">P.O. Box 619, Migdal Haemek, Israel 23105</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form 20-F <font style="DISPLAY: inline;" face="Wingdings">x<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font></font></font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form 40-F <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yes<font style="DISPLAY: inline">&#160;</font> <font style="DISPLAY: inline;" face="Wingdings">o<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font></font>No <font style="DISPLAY: inline;" face="Wingdings">x</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">On June 5, 2014, the registrant announced</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">and Genoray Announce Successful Development of</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Industry Changing CMOS Image Sensor for Medical Diagnostic Devices</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TOWER SEMICONDUCTOR LTD.</font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date: June 5, 2014</font></font></div>
</div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;Nati Somekh</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name:&#160;&#160;Nati Somekh</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title:&#160;&#160;Corporate Secretary</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="QuickMark"><!--EFPlaceholder--></a><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><img src="j3.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-STYLE: italic; DISPLAY: inline">NEWS ANNOUNCEMENT&#160;&#160;</font></font></font></td>
<td width="33%" style="TEXT-ALIGN: center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-STYLE: italic; DISPLAY: inline">FOR IMMEDIATE RELEASE</font></font></font></td>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">TowerJazz and Genoray Announce Successful Development of</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">Industry Changing CMOS Image Sensor for Medical Diagnostic Devices</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Replaces Existing Market Solution with 100um Pixel Size, Higher Resolution, Reduction in X-ray Radiation and Optimized Images for more Cost-effective Medical Equipment</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Market for CMOS Imaging for Medical Electronics is Growing Rapidly from $64M in 2012 to a projected $195M in 2017, a CAGR of 25.1%</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">MIGDAL HAEMEK, Israel and GYEONGGI-DO, Korea, June 5, 2014 &#8211;</font> TowerJazz, the global specialty foundry leader, and Genoray Co. Ltd., a leading manufacturer of digital X-ray devices, today announced collaboration on the successful development of a CMOS image sensor (CIS) for medical diagnostic devices such as X-ray equipment, fluoroscopy and radiography. Genoray utilized TowerJazz&#8217;s 0.18um CIS stitch process to develop the novel device which has a 100um pixel size and contains higher resolution compared to other devices on the market. Also, it has a special feature to control the sensitivity of the pixel which can be applied in various types of medical equipment such as surgical C-Arms and portable X-ray machines.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This new device is a CIS detector whereas the existing market uses a silicon TFT type sensor. The advantage of CIS compared to TFT is that CIS uses active pixels so it obtains the image with less noise and helps minimize X-ray radiation exposure which is currently the biggest issue in the industry. Furthermore, Genoray&#8217;s single detector supports both CT mode and Panorama mode while the existing products in the market only support one by one (CT supports only CT mode, Panorama supports Panorama mode only). This means that by providing multi-functions through one detector, Genoray can satisfy customers who need both modes with a less expensive price point; a competitive advantage of this product.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Genoray is targeting to replace the current market solution with this new, more efficient detector, providing a more cost-effective solution for medical equipment. The imaging device was manufactured using TowerJazz&#8217;s optimized pixel and stitch process which is able to maximize performance and offers a strong pixel structure towards radiographic exposure.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stitching is a technology that enables the manufacture of products where the die size is greater than the area available with a single photo mask. With this technology, it is possible to produce dies up to full wafer size. TowerJazz has many years of production experience with stitching and owns the related patents. In addition, TowerJazz provides a 0.18um CIS PDK with outstanding modeling which helps to implement a very accurate read-out peripheral circuit in a limited timeframe.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As Genoray&#8217;s device can be applied in different types of medical equipment, its expected production volume is sizable, reaching multiple thousand wafer per year run rates.&#160;&#160;Genoray is engaged with numerous local and global supply chains and mass production is expected to successfully start in the near future. According to IHS, the market for CMOS imaging for medical electronics is growing rapidly from $64 million in 2012 to a projected $195 million in 2017, a CAGR of 25.1%.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;We are pleased that Genoray has successfully developed its medical imaging sensor with TowerJazz&#8217;s CIS process and is gearing up to release it to the market. We fully believe that this product will generate great response and demand as Genoray is known for its stable technical solutions and strong business power locally and globally. We hope that this success will bring more opportunities to work continually with Genoray for further technological achievements,&#8221; said Dr. Avi Strum, Vice President and General Manager, CMOS Image Sensor Business Unit, TowerJazz.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;With great support from TowerJazz, finally a new CIS image sensor for X-ray equipment was developed. TowerJazz&#8217;s industry leading CIS process is well-known for superior performance. I have no doubt that the collaboration between TowerJazz and Genoray will bring a successful outcome for production in terms of quality and production size,&#8221; said In Jae Lee, Chief Technology Officer of Genoray.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Besides this CIS detector development, TowerJazz and Genoray are consistently working together and making investments to develop various other innovative applications. &#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About Genoray</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">With the mission of &#8220;Providing Better Tools for Diagnosis,' Genoray, as an industry leader, strives continuously to improve its products and innovation of its diagnostic imaging systems. Founded in 2001, Genoray&#8217;s technical experts' will to manufacture the world&#8217;s best products is still at the heart of its business. With growing demand from numerous local and global customers, the company is increasing the supply of its valuable products through its technological and manufacturing expertise. Genoray will continue to strive to develop higher grade C-Arms, dental X-ray images as well as steadily improve its dental CT and industrial X-ray machines, among others. For more information, please visit: <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">www.genoray.com</font>.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About TowerJazz</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Tower Semiconductor Ltd. (NASDAQ: TSEM, TASE: TSEM), its fully owned U.S. subsidiary Jazz Semiconductor, Inc. and its fully owned Japanese subsidiary TowerJazz Japan, Ltd., operate collectively under the brand name TowerJazz, the global specialty foundry leader. TowerJazz also owns 51% of TowerJazz Panasonic Semiconductor Company, Ltd. through a joint venture with Panasonic Corporation. TowerJazz manufactures integrated circuits, offering a broad range of customizable process technologies including: SiGe, BiCMOS, Mixed-Signal/CMOS, RF CMOS, CMOS Image Sensor, integrated Power Management (BCD &amp; 700V), and MEMS capabilities. Through TowerJazz Panasonic Semiconductor Company, TowerJazz offers best of class 65nm CMOS image sensor dark current and quantum efficiency performance as well as 45nm digital technology. TowerJazz provides a world-class design enablement platform that enables a quick and accurate design cycle. TowerJazz also offers Transfer Optimization and development Process Services (TOPS) to IDMs and fabless companies that need to expand capacity. To provide multi-fab sourcing for its customers, TowerJazz operates two manufacturing facilities in Israel, one in the U.S., and four in Japan. For more information, please visit www.towerjazz.com.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Safe Harbor Regarding Forward-Looking Statements</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This press release includes forward-looking statements, which are subject to risks and uncertainties. Actual results may vary from those projected or implied by such forward-looking statements. A complete discussion of risks and uncertainties that may affect the accuracy of forward-looking statements included in this press release or which may otherwise affect TowerJazz&#8217;s business is included under the heading "Risk Factors" in Tower&#8217;s most recent filings on Forms 20-F, F-3, F-4 and 6-K, as were filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and the Israel Securities Authority and Jazz&#8217;s most recent filings on Forms 10-K and 10-Q, as were filed with the SEC, respectively. Tower and Jazz do not intend to update, and expressly disclaim any obligation to update, the information contained in this release.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">TowerJazz Company Contact in Asia: </font>Shoko Saimiya | 81-795-23-6609 | <font style="DISPLAY: inline; TEXT-DECORATION: underline">saimiya@towerjazz.com</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">TowerJazz Investor Relations Contact:</font> Noit Levi | +972-4-604-7066 | <font style="DISPLAY: inline; TEXT-DECORATION: underline">noit.levi@towerjazz.com</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">G</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">enoray Company Contact: </font>In Jae Lee | +82-31-740-3955 | <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">ijlee@genoray.com</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>j3.jpg
<TEXT>
begin 644 j3.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`$H`
MK`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\HK\(_P!O'_@X!^//PM_;(^)/A?P)X@T&T\*>&==N-)L(I=&M
M[AP+=O)<F1@2V9$<\^M>2?\`$1Y^U-_T-/AO_P`)VU_^)K]3PGA!GF(H0KQE
M32DDTG)W5U?7W=^Y\96XZRZG4E3:DVFUHE;3YG]&]%?B-_P3D_X+M_&OXK_&
M_6KWXH>(-+O/A[X'\+ZEXGURWL=$MX+FXC@B"11HZ@$,UQ+"HY`)(!.#7E7Q
M>_X.:OVA/&/C&YNO"L7A+P;HA<BUL4TU;^54SQYDTN=[XZE50?[(K&'A-GD\
M5+"QY/=2;ES/E5[V7PWO97=E9)K74TEQMET:*K/FU;25E?3KO:WS[G]!U%?S
MHZ/_`,')/[4.FZI;W%QKGA/48(7#/;3Z!"L<X_NL8]K@'_98'WK[$_;,_P""
M\'B]O^";GPE^)_PW^P^$O&GC77KK3M5MIK:.^BMQ9Q,+A(Q*""K/);.K8W!6
M`)SG.>-\*L\PU:C1GR/VLN5-2;2=F]=$UHGJD]B\/QIEU6G.<>9<BNTUJU=+
M36V[74_6JBOSS_X)F?\`!2;QWXP_X)E?$7X]_&O5[/4X_#=]>G3U@L8;)98+
M>"'9&!&H!>6Y=HQGO@5YM_P0@_X*I_&3]O+]IGQGX?\`B-K>FZCHVE>'7U.T
MM[72X+4PR_:H(Q\R*&8!)&&"3Z]:\:MP1F%.GC*S<>7"M*;N[-]HZ:M75[V.
M^GQ#A9RH02=ZRO%66B[O72_3<_56BOPTL_\`@N)^T+\6_P#@H\GP]\(^*=(M
MO!NN>/QH.F1?V):RO'8-?>2K&1D+$B+YBQ->8_%3_@XZ_:-3XG^)%\.>)/#T
M'AX:I=#2XWT*VD:.U\YO)4L5RQ";1D\FO?H>$N=U9J$94[N*EK)Z)[)^[OH_
MN9YE3C?+X1<FI6NULM6M[:[']#-%?SD?\1'G[4W_`$-/AO\`\)VU_P#B:^A?
MV%?^"]?QGUSPO\7?'?Q-OM*\1^&/ASX72YM=-M-,@L6O-4NKV"VM$:5%W!,O
M*6QGY5)P<48[PDSS"T76DZ;LTK*3NVVDDKQ2NVTM6@PW&^75JBIQ4EOJTK))
M7?7LC]LJ*_G.\0_\'(O[46L:U<W5KX@\+Z3;S.6CM+;P_;O%`.RJ90[D#U9B
M:CTG_@X^_:ET_4[>>?Q-X:OX87#/;S>'K98YP#RK%%5P#_LL#[UUKP9S[EOS
M4_3FE_\`(V,'Q]EM[6G]R_S/Z-:_GK_;8_97_:Z_:4_X*A^(@OAKX@R:C#XC
MF'AG6(H[B'2-(T\3G[--#=#$44:Q;&)#!BV[(+DBOUB3_@HX/&'_``2'U']H
MJQM8=&U)O"=U?0VS$2Q6^IH7ME0;OO)]J4`9ZJ1FOQVL?^#AS]K/5)_*MO%^
ME7,I&=D7ABR=L>N!%77X;Y)G5"MBJ^#I4G*%Z3]HVN62WM9.Z[JZOIJ8\5YC
ME]6%&G7G-*5IKD2U72]VOD?T7>&K.ZT[P[86]]<_;+V"WCCN+C;M\^0*`SX[
M9.3CWJ[7\[6@?\'&W[5/@?7(9M9U'PUJT0PQL]2\.1VZ2KGUA\I_Q#5^OW_!
M*3_@IWHO_!3#X+ZAJ\6ECP]XL\,SQVNNZ4)O.CB:128IXF(!,4@5\!AN5D93
MD`,WR?$?A]F^3X?ZYB5&5.^LH.Z5]KII-)O2]K7T['M95Q1@<=4]A2;4NBDK
M7]-6?4]%>6_MN?'M_P!E_P#9)^(7CZ$*U[X:T2XN;%67<LEV4V6Z$=PTS1C\
M:_!Y_P#@X4_:WB0LWB72U51DD^%[3`_\AUCPQP+F.>TIU\&XJ,'9\S:N[7TL
MGMI?U-,XXCPN73C3KJ3<E?17T\]4?T9T5_/!\+?^"^/[7'Q:^)GAWPKI?B[0
M9-2\2ZG;:7:K_P`(W9G,L\JQI_RS]6%?T-V<4D%G%'+*9Y40*\A`4R$#EL#@
M9//%8<4\'8W()4X8V4&YW:46WHK;W2[Z?,TR;/L/F2F\.I)1M>Z2W[6;/R9_
M;S_X(2_LZ_LS_`[Q_P#&3Q/XE^,6KG2BVIW<$>LZ?$][//<*@0,;(A2\LJC)
M!ZU\O_\`!,O]@G]FO_@I;\8=;\*:/H_QS\,1:#I+:K<7]UXGTRYC_P!='$L0
M5=/4[FWD@YZ(:^W_`/@Z'^,P\$_L+^'_``A#-LNO''B2$2QYQYEM:QM,_'M*
M;>O/_P#@U&^#PTOX._%;Q[-%\^MZO::';NPY"VL+328]B;I,^Z#TK].R_.LR
MI\'5LXQ.(FZKERT_>:25XQV6CM[SU['R&*P&$GGT,!2I1Y$KRTOK9O??L0_M
MG?\`!,C]GS_@DI^QYX\\1RW7Q6\26GQ%6R\(W,"ZU807?EM=1WI6&0V95,FS
M!;<C952!@G(\6_X);?\`!+;]FS_@IYIWC.]TVQ^.'A"T\'RVD+277B?3+O[8
M\XE.U=NG+MV"($YSG>*]C_X.P/BM]C^'/PB\#QRY.HZE>ZY<1@]/(B2"(GZ_
M:)OR->H_\&N_PW/A7]@77]?ECVS>*O%MS+&^,;H8(((5'X2+-^=0LTS##<'/
M.IUY_6*L[*7,]D^7;9^[!]!O!X:KGRR^-./LH1U5O*^^^[1^4G_!7W]CWP)^
MPI^V%/\`#KP!J'B/4M.TW2+2ZO9=:N89[A;F8/(5!BBB4)Y1B(!4G)//0#/_
M`&RQ_P`(/^R?^S1X*)*SIX7U#Q?=+V+ZGJ4PC)]_L]I!^!]Z;_P5Q^),GQJ_
MX*:_&+4XF-P$\22Z/!M^8,MF%LUQ['R/UJW_`,%0].^T?MRR>`[26%+;P)I6
MA^"+8NP5(FM-/MH)<GH!Y_G$_4U^L97*M.CE\,5)RFH.I)O>Z@HN_P#X,?W'
MQ>,5.,\5*BK1<E!)=N9M?^DGO7[>GQG/[.W_``1\_9R^`6FS"#4O&NECQUXA
M1#AC:SSR7%JC^H>20M[?95]:R/\`@@9\7%^`OB?]H;QH9!')X7^%.HZE#G^*
M6.:!HU'N7V@>YKYJ_:M^)&I?MC_M.^*-8\.VEY>Z-I-D\&CP!<?8M$TRU*1,
M1T0+;0>8W^TS=2><[X`_%_\`X5=\$OC-I\<OE7/C7P_::%%@X8@ZG:W,@'UC
MMG!]C7*L@4LDG@9KWZTE.IWO4J)ROZ+3TB:O,VLPCB%\--.,?2,6E;U>OS/:
M_P#@A/\`!7_A??\`P4H\)VEU-=16NEV.I:I=7$+`308M)8TE4L"`RS31$$@C
M('!K],_^(6G]GOOXO^+A_P"XKI__`,A5^1_[+SMX%_8R_:'\6JQAN;^PT;P7
M:2YP2U[?B[F4>YATUP?9J^?O[2N?^?B?_OLUSYOD6:9EF-6O@,<\/&"C!I1Y
MKV7/>_,OY[?(VP&98/"86%/$X=57*\KMVM=\MMG_`"W/WQ_XA:?V>_\`H;OB
MW_X-=/\`_D*O'/\`@HC^P+^SU_P2?_8YOM&N'^*_BG3?BMXCT^.ZA@UVPMKU
M18Q74J%9#9LGE!I1N4H26,9##!#?CC_:5S_S\3_]]FOI/]J^=_!7[!_[-OA)
MW=;K5+36_&MY&226^V7WV2W8_P#;&P&/]XUYL>%<XHXO#QQN93K4Y3UCR\OP
MQE-.ZDWHXKYV.MYU@:E"J\/A(TY*.CO?=J+5K+=-GV7_`,$QO^"/?[.?_!2O
MX0Z[XQT]/C7X1L-%U<Z.L=SXBTVZ:YD6&*5F!6P7``E0=Z^./^"N?[(?@;]A
MG]L>^^''@+4?$6IZ=I&EV<]Y+K-Q#/<+<S*92H,44:A?*:(@%2<D\\@#R[X0
M_MG?%O\`9_\`"[Z)X'^)'C3PEH\L[73V6E:M-:0-*P4-(41@-Q"J">N%'I5+
M15\:?MC_`+16DVFI:GK7BWQGXWU.UT]KR\F>[N[J1RD*%G8EB%0*.3@*G8"O
MH<ORC,\)F=7&XK%\V&L^6#;?+MJV^R3Z]3R\5C\'7P<,/1HVK75Y)+7R27R/
MU4_X*,ZJ?V6_^#=KX,?#Z,FWOO'46DK<PCY6VNK:I.3])A&#_O5YU_P:Z?#G
M3['XS_%?XI:W/:Z?H_@CPY'8O>W<BQ06QN93-)(7;`4)':-DD\!^>M3?\'2/
MQ+MK7XN_"/X7Z:PCL/!OAR34#"IX0W$@@C4^ZQVGY/[U\F^(_C/J?P$_X)@>
M%OAQI$\EE<?&?6KSQ9KTB$I)<:;:R"QL[<XZQM<6UW(1ZQIV)KX_)\KK8[A;
MV$'RSQU24F^RE)RD_/W(:=VTCW,=C*>'SGVDE>.'@DEW:227_@4OP/HC_@O!
M_P`%:_AS^W?H^D>`?`/A^>_M/"6M&_7Q=<@0FZ`BEB>&WB*[_)<NCEG*DF)?
MDZ&OF?\`X)U?\%//&W_!-/6O%5]X,T7PSK,GBV"W@NEUB*>18A`TC*4\J6/!
M/F-G.>W2K]I^PM::'_P2=O\`X_:L]P=5UKQE;Z!H4(8K%':(DWGS$?Q,\J;!
MG[HB;KNX^J_^#7GX5>%_BG\7_BQ#XG\-Z#XCAM-'L7@CU33X;Q86,T@)42*=
MI(`R1Z5[%>.2Y3PUB,/2I.K0H2Y91;^*2E&^OE)K9)73LC@I2S#&YM2JSFH5
M*BNFELK.VGHON9EG_@ZB^.+<'P-\+"/^O2^_^2J^@_&G_!5;X@?M`_\`!#GX
MN_$WQKI7AGP[?>);]_!/A^+1XIXA=).L<5Q(3+*Y)"27&,8QY+5^='_!9OQW
MX?\`&W_!1OXBVWA72='T7P_X7NU\/6MMIMI';0![51'.VV,!23<";G&2,5[Y
M_P`%>1_PS'_P3L_98^`,0-O>PZ0_C+7K?HR74X)7([XEN+U>?[HKR<1PSD]1
MY:\+A(TJE:<9M:MJ$8^TDG_Y+%Z=3MI9OCX_6_;5W.-.+CY.3?*G^;^1YY_P
M;W?`/_A=_P#P4Q\*7D\'G:=X$M+GQ+<@C*AHD$4!SV(N)HF'^X:_I'K\D?\`
M@U-^`G]D?"GXF_$RY@(DUS4H/#UB[#!$=M'YTQ7U5GGB'UB/I7ZW5^6>+.:?
M6^()TXO2DE!>OQ/\6U\C[/@G!^PRR,VM9MR_1?@K_,_"#_@Z@^,W_"5?M:^!
M/!$,OF6_A'PXU],H/$=Q>3-N4CU\JWA/T>OT>_X(.?![_A3W_!+WX;QRP^5>
M>)8KCQ!<'&-_VF=VB;_OP(?RK\BO^"JO[-7QP_:E_P""CWQ,\1:9\)_B5?:5
M=ZV-+TZ[3PW>-;2V]LJ6L<J/Y>WRV$6\,#@ALU_0E\'/AW:_"'X1>%?"=D`+
M/PQI%II,&!@;((4B7]%%>SQMB:.$X5R[*J,TV_?DDT[.UVG;^]-_<<'#U*=?
M.<5C9Q:2]U772]E;Y1_$_!3_`(.</BN?''_!1&U\/QR[H/!7AFSLG3/"33-)
M=,?J4FA_(5]]_P#!)?\`;7^!'[+G_!,;X>:%K7Q7^'VGZYIVE7.I7^FRZW;I
M>1SS3S7!B:(MN\P!PNW&<C&*^2O^#@;_`()@?%;Q?^V9J/Q5\#>#]?\`&^@>
M-;2T%TNBV;WMSIUU;VZ6Q1X8P7"-'#&P<#;DL#@@9^!O^'>'Q]_Z(G\6/_"3
MOO\`XU7W&$RC*,\X8P6!GBE",%&32<;\R34DT]M6SYVMCL=EV<8C$1HN3DVE
M=.UKJS5O)(T?V-?#D_[3_P#P44^']MJ(\]O%?C:VOM2W<[HFNQ/<$_\`;,2&
MN$_:9^)K_&?]H[Q[XO:0R'Q/XBO]45NORS7#R+^085]]?\$L_P#@E[\5?A%X
M=^)'QR\6>!_$^BZAX+\(ZM%X/T2XTZ5-5U;5IK.6&-TMMOF[$#D`E069U*Y"
MFODGX6_\$POCQ\3/B1H'AX_"CXAZ,NMW\-DU_J/AR\M[2Q61PIFED>,*J("6
M))Z`U]GA<\RV685YJM'DHPC&_,K7]Z4DM=;+DO;KINCP*V78N.%IQ=-\TY-[
M/;1+\>;\S[N_X(B_\$^?[;_X)_\`QY^*NM6.;[QWX3UCPMX<WIR+46T@N)E_
MZZ3A(P>H^SOV:OR5]J_KP^#_`,"M"^"'P%T+X=Z';B'0/#^D1Z1`I`W/&L>P
MNWJ['+,>[,3WK^7OQ'_P3F^.^C:_?6L?P:^*4T5K<21)+'X6OG20*Q`96$6"
M#C((ZU\=X>\7PS+'YAB<3-14I0<5)I6C:22U[)*_F[GO<49'+"8;"TJ46VE)
M.ROKHW^+=O(_1S_@AMX_^`_[-?[!M[J/QRU3P=8+\0_%MU=:3;>(+(7<=S%8
MP0P>8B-&X!22>9<\'YR!U-?7/_#;_P"P%_T%O@A_X3<7_P`CU^2O[9'[$_QD
M?X8?`CPAHOPH^(^I6OA3P)'<7IM?#=Y,L.H7][=7L\;E8SB1$EA1E/*E,$#%
M>#_\.^?CS_T1;XJ_^$I??_&JRQ'!V59M7J9E7QTH2J2D[1G%*R;4=&KZQ2+I
M9]C,%3AA:>&4E%)7<6W>UW^+9^\0_;>_8#)`&K?!`D_]2W%_\CU^1O\`P7U\
M<:;XG_X*3>)M'T2VL[+0O!6F:=H-A;VL*PP6\:VZSLB(H`0"6XD&`!SFN"_9
MS_X)M?&;Q5^T'X%TO6OA'\2-.T;4?$%A;7]W>>&KR&WMK=[F-99)':,*J*A8
MDDX`!KOOC#^Q9\:/VI_^"C6O:SJ/PH^)-MH?CCQ_(TE]<^&[R.VM[*:_VB1Y
M&C"K&L)!+$X`'I77D&095D>:/$T\6ZB5.5^><79MQM:UM;*1AF>9XS,<'[*5
M!0;FK<L6KZ.]_FT?HU^T%_P2@^$_@?\`X(TZKJEM\.O#=O\`$;0?AS!JUSK:
M6@%\;R"UCN+B3?UW,4D!]B17RW_P:P:SX?/[6/CW2-1TG2KK7)_#J:CI-_<6
MR/<V0AG$4R0R$;D\Q;E=P4C<(QGI7[9?'#P%'\1_@9XO\+B-3'KVA7FEA`.,
M36[QX_\`'J_GH_X)B^#OBW_P3[_:[TKXH>+?A7\2-%\(Z#IFI_VU=WGAV\M[
M>*W-E,07D:,*JB58CDG'`KXKA;,JV;\/9G@\15;J2?-%.6K;5U&-WU<;67?S
M/H,YPD,#FF#KTH6BM'9:::7=O)WOY'#?\%K/C2/CI_P4U^*FHPS>=9Z/J8T"
MV`.55;*-;=P/8RQR-]6-:/\`P6#^!]U^SE\4/A%X/NH6A?1_A7H<;*1@><6N
M&N"/K<&8_4UYE^Q;\/+S]K;]OOX?Z)J0:^G\8>+8+C5&(R9(C/Y]TQ_[9B0U
M^R'_``<'_P#!+KQ1^V;X0\.?$'X=:>VL>,?!EO)87>E1E1/JE@S>8/)SC=)$
MY<A.K"5L98*K?H>.SK"Y'F66936DHPC3DFWHD[*,6^UVI*_GKU/E\/@*V8X3
M%XVG%N3DFEU>K;7W-/Y'R1\:]?L=;_X->?A7#9O&TNF>,WM;I%.3'+]MU.3!
M]RLB-]&%4O\`@W'^+]I^S_IO[27CB^*?9?"7@R+575CCS/):=PGU8@*/<U\F
MV_[)O[4B_"2^\%1_#7XU)X+BU%=6N-'_`.$?OULS>!?*$WE&/!DVG&0,X'H.
M-'P_9_$']C3]DKXN:%XK\&^+O!MS\53I&BVKZOI-Q8?:((+B6ZN/+,J+NQY4
M2,!GB;WJZ^2X>KEN*RR%:,_K%;GLFKJ,ZD9-6ONE=^A%+,*L,71Q<J;C[*GR
MZK2\8M+[W8Y;]B+X47O[97[?/@+P[J1DU"7QCXHCNM7=N6E@$IN+MS[^4DIK
MU;_@O%\=Q\=?^"FGCTV\PETWP<8?#%F`<B,6J8F4?]O+7%>N?\&VGPL=_P!H
M;XC_`!7ETR[U6W^%?A*XFMK>V@::::\N5<)'&J@EG:&&Y4*`22P'>ODSQM^Q
MM^T#\0/&>KZ_J7P>^*LVHZW>S7]U(?"E_EY99&D=O]5W9B:]*&+P\^)*CJ3C
M&.'I1@DVE[U1\SM?M&,5\SEE1JQRJ*A%MU9N3LF](JRO\V_N/Z(O^"/_`,!#
M^SC_`,$X_A9H$L`@O[S2%UJ^!&'\^]8W+!O=1*J?\``KZ5K^>_\`9^^)'[?O
MC[XQ^#/"]]J7Q[T+1=5U:STZYN[G1;JVM=/MGE1'D9VA"HB(2<D@`"OZ#U78
MH&2<#&3R:_F[CC(ZN`QKKUZ\*LJSE-\C;M=WU];Z>A^L<.YC#$X=4Z=.4%32
MC[RM?3H+17S_`!_\%4/V>[F#5)+;XI^&[S^Q83/>I;&6>2!`RIDJB%C\SH,`
M$DL*]^2570,#@,,\\5\GB<#B<-;ZQ3E"^W,FK[=UYK[T>W2Q%*K?V4E*W9I_
MD.HKAOCC^TQ\/_V:=&M+_P`>^+M#\*V^H2&*T^WW(CDNW`R5B3[\A`()V@X!
MYH^'_P"TIX'^*OBR'1/#OB&TU?4;C0K;Q-&ENDC(^G7+O'!<;]NS#M&^%SNP
MN<8P:2P>(=+VRA+D[V=M-]=M`>(I<_L^9<W:ZO\`<=S17,ZE\8?#FD?%;2O!
M%QJ<:>*-:L+C5+.Q$;LTMM`\:2RE@I555I8Q\Q!);C.#C=UC6+;0-)NKZ\F2
M"TLHFGFD;A8T52S,?8`$UC*G.-KIJ^J\UM==]58T4XN]GMN6:*\H\4_MR?";
MP/\`"3PSXZUOQQHVD>%_&4*7&B7=X7@;4HV02!HXF42$;"&/R\`@G%>HV.HP
M:G8PW,$JRP7"+)&XZ.K#(/X@UI5PM:DE*I!Q3;6J:U6C6O5/?L1"M3F[0DGL
M]'WV^_H344;AZUA>'_B7HGBGQAK^@6%_'<ZOX7:!-4MPC@VAGC\V($D!3N0[
MOE)QWQ648.2;2O;5^2O;7YM+U+<DK)O<W:*XS5/VA/!>A?$F^\(W_B+3K#7]
M-T^VU2YM[EC"D-O<3M;P,96`CS)*C(J;MQ(Z=*[/</454Z4X6YXM7U5UNO(4
M:D97Y7>Q3\1ZROAWP]?Z@\%S<K86\EP8;>)I9I0BEMJ(H)9CC``!))`K^;K]
MH?\`;-_;._:NL=<\!:]%\3[O0=>NY"WAVW\+M#(8VEWK;L8[=9G1>!M9B#M&
M<U_01\./VP?AE\7_`(GZMX+\,>,]&UOQ1H33I?Z?:NSRVI@E$4P;C`V2$*>>
MIKTC*Y!R,U]CPSQ#'A^K.6)P<:DY<KBYJSC:[3C>+WONK;+4\+-\K>9PBJ5=
MPBKI\NJ=[:.SZ=O,_)O_`((%_P#!&WQ7^SGXZ;XS?%?2SH>OQVDEKX<T.<@W
M5B)5VRW4X'^K<QEHU0G<`[E@#@5^LM)N'J*YL_&#PX/B\/`?]IQGQ8='_M[[
M`(W+"R\[R/.+[=@!E^4`MN.#@8!->3G^>XW/,;/'8E7E;9+2,5T6^B[OJ[G;
MEF78?+L/'#TM%?=[MO\`4Z6OQ8_X.5/!?Q6_:._:7\%^&O!_PX^(7B?PUX-T
M1IVO-*\/7EY:O>W4N9%$D<;(Q6*&#H>"S"OVF#`]"#6'X0^)N@>/M2UZST75
M;34KGPQ?G2]5CA;<;&Z$:2F%_1PDB-CL&%:\*Y[/)\>LQITE4<$][I*^E[KU
MM\R,YRZ./PSPLI\JDU\[:V_4_FG_`&=M)_;._9+TK4K'X<>#/CCX1M=8E2>]
M2R\'W@^TNBE5+%K<DX!./J?6OUD_X(+>(/VD/B-8?$/Q!\?=2^("Q6\EI8:'
MI_B;3GL'W8DDGF5'C1F&#"H;D?>'6OT0W#&<\5S?Q%^+_ASX3S>'HO$&I1Z?
M)XKU>'0=*4QO(UY>RJ[QP@(IP2L;G+84!2217TW$/'[SK#U,.L%3C4G:\TKS
MT:>]K[*SUV/(ROAE9?4C5^L2<8W]UNT==-KVW?WG2T4F\8!R!FEK\UN?6GP=
MX_\`V#OB!\4?A7\0]"U+2$@D^+?QMMM<UQH=2BCFMO"]K/;>4ZR*^0_E6,1"
M(=ZF;H,''DFO?\$Z?VA=7TGP'X=N+SQ79^"EU#6[F[L-)\41M?>&Y+C6&DM9
M1--<KY@CL@@1P9VC9I/W>YLU^IE%?68?C+'45RPC&U[JZ;L^7DTUZ1LEZ+SO
MXE7(,/4=Y.6UM^E^;MWO][/B;]MC]F_XP']J._\`B)\.]!D\62ZE\/&\(Z/=
M0:U:6&H^#]1%T\_VR/[6K1-',#&DA0>9M0@#!%>9>+OV(OC[=^(M2\1ZUI][
MXQ&H7_A;3O$.G6/B*'3+[Q9I>FZ/(+C$ZNBQQR:I<22/$60ND?`Q@'])J*RP
MO%>)H4XTXTX.T>6[3NTFFM5)6M96Y;:Z_%J76R6C4FYN4M7>UU:]FMK:WOUO
MVVT/REU__@E[\?O$5UX/TS5C>7^KVO@JST"Q\66WB^6!/!TQUN:_N3(/,6XN
MVAMC;P1<,C&)22,`C7^(7[$O[2OCOXA^,O$5WHE]>:_)8^,K2UU%_&,;6VJ_
M;HA::3!#:F01V]O!;2.X#*&,H=FP=I/ZAT5V_P"O6.NFZ<'OT?VM_M:)]4M+
MZVOJ<_\`JYAK64I=.JZ;=-UWWMI>VA\/?MB?LE?$-_#GP9T+X2>%M0MO%GPJ
MTNVLO#WC:#Q!:V=CHH*PV]U;W=G*&>YMY+>!20B,2<`8YSX7\$O@C\;OVH?B
M-XK^*?@>;6?#)G\0^-+W1O$=_P")'-EJ,30SZ;IEC!8"1ECC2XB$[R21C_5J
M5W<`?JK0``,``"N;"\6UZ.'=%4XN6JYG=NTKN2:;LTV[I:13N^5N5S6MD=*I
M54^=I:.RLM5:S6FEEUW>FME8_+WX;_L(?'?PC\)/#Z:SI?CSQ+8:CXGCN_&_
MA!O&L%C-J\$.G&**6&Y6Z?\`=O=-YDZO.'F\M"47&!J?&K]BC]H35!XAM-(T
M34-6\,Z]XC\27,.AQ^,18)!`FGVMEX?::02[GMH_)EF:`-DR.AD'!(_2ZBM?
M]=<9[7VSIPOKTE;7R4MUI:2][2.K21*X?H<G(I2Z=5_EL^JVU>FI^7FL_P#!
M+SXD>(#HK>)O#$_B.QM/$G@2QOHF\1I%=7&C:1I,J7EP91*"2;^YE8KN\PA=
MRC.TUZM_P33\`^(O'GQC^(7Q'&KZKK?PQT#6-9L_AM#)<S+%JL=Y=?:+BZ`E
M(W1(52VA8Y4*LI7@@U]VTD<:Q(J(JHJC``&`!Z5GB^+L5B<-.C5BM4DFKV2L
MD[)WU:2C=-:.2:=TU5'(Z-*K&I!O2[]7TU[)N]M=;>=_SI\._P#!/3XP_"W]
MBOPCIUOJ_C'Q#K^K^)+;6_'W@R#Q';6,$UK+=7%U?6EE<H(]C22RQ^86G(=5
M<!@&P>2US]B/]J7PY\/;70-*@N-3.K>`M3T"%T\7@1^$9M0UP7#1[Y7$EP]O
MIX2&.09P0X#`;<_J)15PXTQJDYRIPDW)S=XO=W[-;7MW:T;:%+(,.THJ4E9<
MN_3YK_@=4D?G/J7["/QYM/B_=>-?#]WJNFZ^=>\87FGRW/B=I;.QLCI7V+0H
M/L_FF(B28),YV$J4&_&`!Q/PN_X)F?&#5_$Z7FJZ!K_@Y/$.I>$+/7;\>-Q>
M:O)I]E'=W.K7+72S&027%XT`"QG@,"!P<?J=13AQKCHP<%&&RC>SNDI<R^U;
M1[73LO5W4N'L,Y7;ENW:ZW:L^G7K;_(^"OV,OA#JGCC]O+Q_J&A:WJ]S\"_A
MIK;2>'HWN[EHK_67TRTL;B`-*<S0V9@N?53-<YR60FN<O/@)^TI)^S9\8_"&
MC>![CPMX@\;^.;SQ=)K4'B>S,FKVEQJ41>RA$<JO%(;&-4W/)&"(V7<I8$?H
MND:Q+M155>N`,"EK"7%-95E45.+25-)2N_X>J;LXW<G=RNG=]K(TCDT/9\KF
MU?FO:R^+HKWM9:*S/RL^*7_!/7]H77/A=H_@[3+3Q9JVAGPXYLDO?&<5D?#.
MKW&KM+<RO'#,1-Y=D52W022)$"XW%N3M>,?V"?V@O'?[1.H>)GTMH-;\/:GX
MJOO#WBB\\4+<VR))ITEKH$,%GO/V=(3)N9BF_P`S<S9SD_IS174N.,:E;V</
MM=']OXOM6U[6LWJTWJ8OAW#WOS2Z=5]G;I^._1:'YI?L[_\`!-GXK:K!X`TK
MQS<>/].\.W7B.ZU?QI;R^+$0M'#I`MH$B-O=22E;JXFE,Q\PLXBW,(]R@?I8
MB"-%51A5&`/2EHKP\XSO$9C.,ZZ2M>R2LM7>^[UV7HEV/1P&7TL)%QIW=^_I
';_@^K9__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
